GENE TO PATIENT Trademark

Trademark Overview


On Tuesday, September 19, 2000, a trademark application was filed for GENE TO PATIENT with the United States Patent and Trademark Office. The USPTO has given the GENE TO PATIENT trademark a serial number of 76131079. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, November 14, 2003. This trademark is owned by Millennium Pharmaceuticals, Inc.. The GENE TO PATIENT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and consulting services and data analysis in the fields of genomics, diagnostics, pharmaceuticals, clinical trial design and biotechnology; computer services, namely, providing access to databases of life sciences information via global, national, and local computer networks; computer services, namely, creating and customizing databases for others in the field of life sciences; computer services, namely, custom software development; computer services, namely, software support and maintenance; computer services, namely contract computational services; consulting services, namely, research, development, validation and testing services for others in the fields of genomics, life sciences and pharmaceuticals medical and diagnostic services, namely, diagnosing preventing, and predicting diseases, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative progra...
gene to patient

General Information


Serial Number76131079
Word MarkGENE TO PATIENT
Filing DateTuesday, September 19, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, November 14, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 21, 2001

Trademark Statements


Goods and Servicesresearch and consulting services and data analysis in the fields of genomics, diagnostics, pharmaceuticals, clinical trial design and biotechnology; computer services, namely, providing access to databases of life sciences information via global, national, and local computer networks; computer services, namely, creating and customizing databases for others in the field of life sciences; computer services, namely, custom software development; computer services, namely, software support and maintenance; computer services, namely contract computational services; consulting services, namely, research, development, validation and testing services for others in the fields of genomics, life sciences and pharmaceuticals medical and diagnostic services, namely, diagnosing preventing, and predicting diseases, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatments based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services namely, identification and characterization of peptides and proteins for use in developing diagnostic and therapeutic products and services; research services, namely, identifying genes; drug screening using cultured microorganisms; chemical and genetic engineering of therapeutic molecules; pharmaceutical research and development services rendered to others; research services for discovering antibodies, antigens drugs, peptides, proteins, and gene therapy drugs; providing an online electronic database on global computer networks in the field of genomics, diagnostics, pharmacogenomics and biotechnology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 27, 2000
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMillennium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events


Event DateEvent Description
Monday, January 12, 2004ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 7, 2003EXTENSION 3 GRANTED
Thursday, May 8, 2003EXTENSION 3 FILED
Wednesday, May 7, 2003TEAS EXTENSION RECEIVED
Monday, November 25, 2002EXTENSION 2 GRANTED
Wednesday, November 6, 2002EXTENSION 2 FILED
Wednesday, November 6, 2002TEAS EXTENSION RECEIVED
Wednesday, May 29, 2002EXTENSION 1 GRANTED
Monday, May 13, 2002EXTENSION 1 FILED
Monday, May 13, 2002PAPER RECEIVED
Tuesday, November 13, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2001PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2001NOTICE OF PUBLICATION
Friday, May 4, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 7, 2001ASSIGNED TO EXAMINER
Tuesday, February 27, 2001ASSIGNED TO EXAMINER